Dear #ThermoOncology Followers,

I am thrilled to announce the completion of our first multi-center #breastcancer research collaboration, in partnership with four hospitals/universities. Our findings will soon be published in a prestigious journal, marking a significant milestone in our journey in #ThermoOncology #breastcancer #earlydiagnosis.
Through the evaluation of radiomics features derived from 18F-FDGPET/CT images, we have identified a correlation between four important immunohistochemical biomarkers (E.R., PR, HER2, and Ki67) in breast cancer. The molecular markers ER, PR, HER-2, and Ki-67 are widely used in predicting breast cancer prognosis and guiding therapeutic decisions. Furthermore, our research highlights the potential for future research to develop more robust radiomics models for predicting IHC factors in breast cancer. This ongoing research has the potential to advance our understanding and application of radiomics-based predictive models in clinical practice. In #ThermoOncology we believe finding #breastcancer early and getting state-of-the-art cancer treatment #hyperthermia besides clinically routine treatment strategies are two of the most important strategies for preventing deaths from breast cancer.

#cancertreatment #hyperthermia #ThermoOncology #livelifetothefullest